Trial of 5-Minute Subcutaneous Rituximab Injection: Positive Results ProHealth Dec 8: Basil, Switzerland-based Roche pharmaceuticals company reports positive results from two international phase III trials of its MabThera – a form of rituximab that can be injected under the skin rather than delivered intravenously. Rituximab is ... Roche announces positive studies of MabThera with subcutaneous injection |
